Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Manufacturing
Fierce Pharma
Medline earns FDA warning letter ire for repeat bacteria issues
Medline was slammed for a second time since April by an FDA warning letter that outlined the presence of toxic bacteria in finished products.
Joseph Keenan
Jun 4, 2026 7:36am
Fierce Pharma
Lilly, Boehringer slash investment plans in Germany
Jun 3, 2026 3:10pm
Fierce Pharma
Novo becomes latest drugmaker to strike OpenAI pact
Apr 14, 2026 10:13am
Fierce Pharma
Trump slaps 100% duties on imported drugs, with exceptions
Apr 2, 2026 4:59pm
Fierce Pharma
FDA delays decision on Orca Bio’s cell therapy for blood cancers
Apr 1, 2026 8:00am
Fierce Pharma
Novartis pledges nearly $480M to bolster China production, R&D
Mar 23, 2026 10:35am